Remdesivir is an nucleotide-analog prodrug with broad spectrum antiviral activity against RNA viruses. Remdesivir has demonstrated in vitro and in vivo activity in animal models against the viral pathogens MERS and SARS
We use some essential cookies to make this website work. These cookies aren't used to track you. We'd
like
to set additional cookies to understand how you use our website. This information is used to improve
our
services.